MOLIMM Technology
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Our focus on cardiovascular disease research and treatments
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
The impact of cardiovascular disease
Cardiovascular disease
~20.5M
Annual deaths worldwide from cardiovascular disease in 2021, ~900K annual
Hypercholesterolemia
~24.1%
Percentage of adults worldwide living with hypercholesterolemia (also known as high
Cardiovascular disease
We continue to build on our history of innovative therapies in heart disease to help increase our understanding and help patients around the world.
Hypercholesterolemia
Hypercholesterolemia, a type of hyperlipidemia, is a disorder in which there are elevated LDL cholesterol (LDL-C) levels in the blood. About 24% of adults worldwide have hypercholesterolemia, also known as high cholesterol, which is a major cause risk factor for atherosclerotic cardiovascular disease (ASCVD), a leading cause of death. People who have elevated LDL cholesterol levels often have no symptoms, so they may not know they have high LDL cholesterol.
Read the stories
Oncology
Our teams of researchers and scientists are pushing the boundaries of cancer research to discover more effective anticancer therapies.
Vaccines
Our teams of researchers and scientists are pushing the boundaries of cancer research to discover more effective anticancer therapies.
Infectious diseases
Our teams of researchers and scientists are pushing the boundaries of cancer research to discover more effective anticancer therapies.
Cardio-metabolic disorders
Our teams of researchers and scientists are pushing the boundaries of cancer research to discover more effective anticancer therapies.
Relevant information about MOL and IMM
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou Founded in 2002, Cellex Incorporated is a biotech company that develops technologies.
The importance of integration
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
The importance of integration
Founded in 2002, Cellex Incorporated is a biotech company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly for point-of-care (POC) professional healthcare settings. Based in Morrisville, NC, the company maintains both a GMP manufacturing site in Suzhou.
Discovery & development
We're focused on transforming novel science into groundbreaking medicines and vaccines for patients.
Drug discovery
Drug discovery and development is a complex and lengthy endeavor. It requires creativity, tenacity and agility and the expertise of thousands of scientists working diligently toward our goal to save and improve lives around the world.
Meet our scientists
Innovation is fueled by diverse expertise and backgrounds. Our R&D leaders are pushing scientific boundaries at Merck. Meet our scientists.
Dean Li
Senior vice president and head, discovery, preclinicaldevelopment and translational medicine
Dean Li
Senior vice president and head, discovery, preclinicaldevelopment and translational medicine
Dean Li
Senior vice president and head, discovery, preclinical development and translational medicine
